Create Alert
Watchlist

Syncom Formulations (India)

₹17.39
+0.02 (0.12%) 1D
NSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this

Performance

Open
17.34
Prev. Close
17.37
Volume
4,53,370
Total traded value
0.79 Cr
Upper Circuit
18.23
Lower Circuit
16.50

Fundamentals

Market Cap₹1,633Cr
ROE14.45%
P/E Ratio(TTM)28.48
EPS(TTM)0.61
P/B Ratio4.77
Dividend Yield0.00%
Industry P/E35.33
Book Value3.64
Debt to Equity0.01
Face Value1
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About Syncom Formulations (india)

Syncom Formulations manufactures and sells over 200 pharmaceutical products, including tablets, capsules, liquids, and various types of injections. The company operates on the principle of a 'synergistic combination of commitment and consistency' to maintain its reputation in the industry. As a leading vaccine manufacturer, it contributes to India's global market share of about 60%.;
Parent OrganisationSyncom Formulations (india)
Managing DirectorShri. Vijay Bankda
NSE SymbolSYNCOMF

Shareholding Pattern

Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Promoters
50.57%
Retail And Others
49.02%
Foreign Institutions
0.41%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
Torrent Pharmaceuticals
NA
(0.00%)
61.75
Gland Pharma
NA
(0.00%)
43.16
Ajanta Pharma
NA
(0.00%)
34.16
Eris Lifesciences
NA
(0.00%)
57.46